This is also supported by melanoma TCGA data analysis where we found that composite high mRNA expressions of PLK1 and N-cadherin significantly decreased overall survival of melanoma patients, and low PLK1 with high E-cadherin expression was associated with a trend of higher overall survival. This evidence concerns the gene PLK1 and melanoma.